Janssen Submits Application To U.S. FDA Seeking Approval Of STELARA® (ustekinumab) For Treatment Of Moderately To Severely Active Ulcerative Colitis iData Research 18/01/2019 Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supple... Read More
